A sweeping overhaul of the CDC’s top vaccine advisory panel is ripping through the medical world, while rattling pharma and biotech stocks.
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To ‘Restore Public Trust’ — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading